Upcoming Live Webinar on Psychedelic Science
Clearmind Medicine Inc. (NASDAQ: CMND), a leading clinical-stage biotech company, is thrilled to announce an engaging live webinar titled "Gazing Through the Crystal Ball." This event will take place soon, featuring a panel of esteemed experts who will dive into the transformative world of psychedelic research and its implications in healthcare.
Panel of Distinguished Experts
The webinar will host a significant group of experts renowned for their contributions to psychedelic science. Among them is Rick Doblin, PhD, the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS). Doblin's passion lies in establishing legal avenues for the effective therapeutic use of psychedelics and cannabis, highlighting their potential benefits not only as medicines but also for personal development.
Leading Voices in the Field
Robin Carhart-Harris, PhD, an esteemed neuropharmacologist and psychologist, will also extend his expertise. Currently a distinguished professor at the University of California, San Francisco, his work is pivotal in understanding how psychedelics can alter brain function and improve mental health therapies.
Additionally, the CEO of Clearmind Medicine, Dr. Adi Zuloff-Shani, is stepping forward to share insights about their groundbreaking treatment for Alcohol Use Disorder (AUD), CMND-100, which has advanced to the stage of FDA-approved clinical trials.
Insights into Regulatory Changes and Opportunities
Mark Haden, VP of Business Development at Clearmind and a well-respected advocate for drug policy reform, will present on how changes in legislation are reshaping the landscape for psychedelic research and therapy. He emphasizes that we are witnessing a unique convergence of clinical research and policy that opens up new possibilities for treatment approaches.
Innovative Moderation
The discussion will be moderated by Shannon Smadella, a recognized social entrepreneur with a wealth of experience in psychedelic advocacy. Her guidance will ensure that critical questions about the industry's future are explored thoroughly.
Register for an Insightful Discussion
This interactive webinar promises to be a vital touchpoint for anyone interested in the future of psychedelic science. As quoted by Haden, the session will tackle not just current research but the broader implications of policy and ethics in this evolving sector.
Dive Deeper into Psychedelic Therapeutics
Clearmind is committed to developing cutting-edge psychedelic-derived therapeutics aimed at addressing substantial health concerns, such as alcohol use disorder. With a robust intellectual property portfolio that includes numerous patents, Clearmind is well-positioned in its field, intent on advancing the frontiers of psychedelic medicine.
Contact Information
To learn more about Clearmind Medicine and register for the upcoming webinar, you can reach out directly at invest@clearmindmedicine.com. For inquiries, the company’s dedicated team is ready to assist. You can also contact them via telephone at (604) 260-1566.
Frequently Asked Questions
What is the purpose of the "Gazing Through the Crystal Ball" webinar?
The webinar aims to discuss the evolving psychedelic science landscape and current changes in regulations affecting the field.
Who are the featured speakers in the webinar?
Notable speakers include Rick Doblin, Robin Carhart-Harris, and Dr. Adi Zuloff-Shani, each renowned in their field.
When is the live webinar scheduled to occur?
The live webinar will take place shortly. Keep an eye on the official announcement for specific date and time details.
How can I register for the webinar?
You can register by visiting the official Clearmind Medicine website or by contacting their team via email.
What are the key topics that the webinar will cover?
The discussion will include advancements in psychedelic research, regulatory changes, and the therapeutic potential of psychedelics.
